
Two suppliers, DuPont and Inbiose, worked together to refine the technique for synthesizing human milk oligosaccharides (HMOs), and specifically the HMO 2’-fucosyllactose (2’-FL), so that these ingredients can be cost-efficient enough for commercialization.






























